Keep Your Fingers Crossed: FDA Approves Artificial Pancreas Outpatient Trial

The FDA has approved the start of outpatient trials of a smart phone-based monitoring device that functions as an artificial pancreas. If the device, which automatically measures blood glucose levels and adjusts them with insulin, is successful, several million type 1 patients could enjoy a whole new level of convenience.

Keep Your Fingers Crossed: FDA Approves Artificial Pancreas Outpatient Trial

Leave a Reply

Your email address will not be published. Required fields are marked *